46. 悪性関節リウマチ Malignant rheumatoid arthritis Clinical trials / Disease details
臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04434118 (ClinicalTrials.gov) | March 20, 2020 | 13/6/2020 | Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients | Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients: A Retrospective, Case-control Study | Rheumatoid Arthritis;COVID | Drug: Traditional antirheumatic drugs | Sadat City University | NULL | Withdrawn | 18 Years | 60 Years | All | 0 | Egypt |